Govt Job: For M.Pharm, MS Pharm, M.Sc for a project sponsored NIPER

The National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is an Institute of National Importance with the proclaimed objective of becoming a Centre of Excellence for advanced research in pharmaceutical sciences.

The NIPER-Mohali was the first institute established in the year 1998 under the aegis of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Later, the DOP established 6 new NIPERs across the country including NIPER-Hyderabad which started functioning on 19th October 2007, from the premises of the erstwhile R&D Centre of IDPL, Balanagar, Hyderabad.

Post: Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow (JRF) to work on the following project sponsored by Science and Engineering Research Board, Department of Science and Technology, Government of India (SERB-SRG) under the supervision of Dr. Amol G. Dikundwar in Solid State Characterization group at Department of Pharmaceutical Analysis, NIPER Hyderabad.

The title of the project is Co-amorphous Forms for Bioavailability Enhancement of Poorly Soluble Drugs: Design, Synthesis, Characterization, and in vivo Studies.

Essential Qualifications: M.Pharm./M.S.Pharm with Pharmaceutics/Pharmaceutical Technology/Pharmaceutical Analysis specialization or M.Sc. Chemistry/Physics with Materials Science specialization/curriculum. Candidates with sound knowledge and demonstrated experience (e.g., Masters’s project thesis) in the field of solid-state pharmaceutics are preferred.

Age not exceeding 35 years as of the last date of application.

Salary: 31,000/- per month (plus HRA as per DST norms)

How to Apply: A detailed resume including the applicant’s personal details with photographs, educational background, statement of purpose, professional reference for a recommendation, and a copy of all credentials should be submitted by email (amol.dikundwar@niperhyd.ac.in). An incomplete application will not be considered.

Last Date of Application: 29th October 2022

Date of Interview: Interviews will be held as soon as possible thereafter.

Note: Only shortlisted candidates will be intimated to appear for an interview (online or offline); no TA/DA will be paid for attending the same.

Dr. Amol G. Dikundwar
Department of Pharmaceutical Analysis,
NIPER-Hyderabad, 500037.
Email: amol.dikundwar@niperhyd.ac.in

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore